Key Highlights
- Pensar Medical partners with Centurion Therapeutics to distribute Microdoc® sNPWT.
- Microdoc® sNPWT system offers cost-effective, efficient treatment for chronic and acute wounds.
- The strategic partnership targets over 600 sites of care with 500+ sales professionals.
- The sNPWT market is valued at $400 million and growing by 20% annually.
- Potential to reduce surgical site infections by more than 50% with sNPWT.
Source: PR Newswire
Notable Quotes
- “We are thrilled to partner with Centurion Therapeutics. Their strong presence and rapid growth in the inpatient market, combined with our novel NPWT technology, will enable us to reach more patients and improve outcomes.” — Jason Bandy, CEO at Pensar Medical
- “Adding the Microdoc® sNPWT system to our product portfolio aligns perfectly with our commitment to providing comprehensive wound and surgical management solutions nationwide.” — Robert Goodwin, President and CEO at Centurion Therapeutics
SoHC's Take
This partnership between Pensar Medical and Centurion Therapeutics marks a significant advancement in the wound care industry. By leveraging Centurion’s extensive distribution network and Pensar’s innovative NPWT technology, the collaboration is poised to greatly enhance the accessibility of advanced wound management solutions. The integration of the Microdoc® sNPWT platform into a growing market, especially with its potential to significantly reduce surgical site infections, represents a critical step forward in improving patient outcomes and reducing healthcare costs.
